CLINICAL_TRIALS
trial_result
· 2014-07-11
Clinical Trial Update: Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Summary
Phase 3 clinical trial of Ba253BINEB in chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED